ﻻ يوجد ملخص باللغة العربية
Magnetic resonance imaging (MRI) has great potential to improve prostate cancer diagnosis. It can spare men with a normal exam from undergoing invasive biopsy while making biopsies more accurate in men with lesions suspicious for cancer. Yet, the subtle differences between cancer and confounding conditions, render the interpretation of MRI challenging. The tissue collected from patients that undergo pre-surgical MRI and radical prostatectomy provides a unique opportunity to correlate histopathology images of the entire prostate with MRI in order to accurately map the extent of prostate cancer onto MRI. Here, we introduce the RAPSODI (framework for the registration of radiology and pathology images. RAPSODI relies on a three-step procedure that first reconstructs in 3D the resected tissue using the serial whole-mount histopathology slices, then registers corresponding histopathology and MRI slices, and finally maps the cancer outlines from the histopathology slices onto MRI. We tested RAPSODI in a phantom study where we simulated various conditions, e.g., tissue specimen rotation upon mounting on glass slides, tissue shrinkage during fixation, or imperfect slice-to-slice correspondences between histology and MRI. Our experiments showed that RAPSODI can reliably correct for rotations within $pm15^{circ}$ and shrinkage up to 10%. We also evaluated RAPSODI in 89 patients from two institutions that underwent radical prostatectomy, yielding 543 histopathology slices that were registered to corresponding T2 weighted MRI slices. We found a Dice coefficient of 0.98$ pm $0.01 for the prostate, prostate boundary Hausdorff distance of 1.71$ pm $0.48 mm, a urethra deviation of 2.91$ pm $1.25 mm, and a landmark deviation of 2.88$ pm $0.70 mm between registered histopathology images and MRI. Our robust framework successfully mapped the extent of disease from histopathology slices onto MRI.
The interpretation of prostate MRI suffers from low agreement across radiologists due to the subtle differences between cancer and normal tissue. Image registration addresses this issue by accurately mapping the ground-truth cancer labels from surgic
Magnetic resonance imaging (MRI) is an increasingly important tool for the diagnosis and treatment of prostate cancer. However, interpretation of MRI suffers from high inter-observer variability across radiologists, thereby contributing to missed cli
Joint analysis of multiple biomarker images and tissue morphology is important for disease diagnosis, treatment planning and drug development. It requires cross-staining comparison among Whole Slide Images (WSIs) of immuno-histochemical and hematoxyl
Building robust deep learning-based models requires diverse training data, ideally from several sources. However, these datasets cannot be combined easily because of patient privacy concerns or regulatory hurdles, especially if medical data is involv
Prostate cancer is the most prevalent cancer among men in Western countries, with 1.1 million new diagnoses every year. The gold standard for the diagnosis of prostate cancer is a pathologists evaluation of prostate tissue. To potentially assist pa